Healthcare

Pharma Giant Trials IBM Blockchain in Bid to Improve Clinical Trials

Pharma giant Boehringer Ingelheim is set to trial IBM blockchain in Canada to raise the quality of processes and records in clinical trials.

A CoinDesk investigation reveals that health startup Doc.com has used overstated claims to gin up investor demand.